2020
DOI: 10.7275/16089842
|View full text |Cite
|
Sign up to set email alerts
|

Rare Diseases in the United States: Establishing prevalence, the insurance experience, and orphan drug expenditures in Medicare Part D

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles